Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-Jun-23 5:10 PM View:  | Roivant Sciences Ltd. (ROIV) | 22-Jun-23 | Private Sale | 13,000,000 | $9.90 | $128,700,000.00 | (15%) 88.24M to 75.24M | |
| 13-Nov-20 9:00 PM View: | Adaptive Biotechnologies Corp (ADPT) | 11-Nov-20 | Sale | 2,500,000 | $49.51 | $123,787,000.00 | (7%) 33.49M to 30.99M | |
| 30-Jan-20 4:53 PM View: | Adaptive Biotechnologies Corp (ADPT) | 28-Jan-20 | Sale Duplicate | 4,912,900 | $24.98 | $122,706,000.00 | (13%) 38.41M to 33.49M | |
| 02-Jul-19 5:13 PM View: | Adaptive Biotechnologies Corp (ADPT) | 01-Jul-19 | Conversion Duplicate | 36,731,600 | -- | -- | 2578% 1.43M to 38.16M | |
| 02-Jul-19 5:13 PM View: | Adaptive Biotechnologies Corp (ADPT) | 01-Jul-19 | Purchase Duplicate | 250,000 | $20.00 | $5,000,000.00 | < 1% 38.16M to 38.41M | |
| 28-Jun-19 7:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 27-Jun-19 | Conversion Duplicate | 21,915,100 | -- | -- | 100% 0 to 21.92M | |
| 28-Jun-19 7:02 PM View: | Bridgebio Pharma, Inc. (BBIO) | 27-Jun-19 | Purchase Duplicate | 4,705,900 | $17.00 | $80,000,304.00 | 21% 21.92M to 26.62M | |
| 19-Jun-19 6:29 PM View: | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
| 19-Jun-19 6:29 PM View: | Urovant Sciences Ltd. (UROV) | 18-Jun-19 | Market Purchase (Planned) Duplicate | 6,706 | $8.21 | $55,061.00 | < 1% 22.85M to 22.86M | 98% |
| 19-Jun-19 6:29 PM View: | Urovant Sciences Ltd. (UROV) | 17-Jun-19 | Market Purchase (Planned) Duplicate | 6,541 | $8.53 | $55,824.80 | < 1% 22.84M to 22.85M | 90% |
| 14-Jun-19 6:16 PM View: | Urovant Sciences Ltd. (UROV) | 14-Jun-19 | Market Purchase (Planned) Duplicate | 7,144 | $7.91 | $56,514.00 | < 1% 22.83M to 22.84M | 105% |
| 14-Jun-19 6:16 PM View: | Urovant Sciences Ltd. (UROV) | 13-Jun-19 | Market Purchase (Planned) Duplicate | 7,367 | $7.95 | $58,542.60 | < 1% 22.83M to 22.83M | 104% |
| 14-Jun-19 6:16 PM View: | Urovant Sciences Ltd. (UROV) | 12-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $8.30 | $62,244.00 | < 1% 22.82M to 22.83M | 95% |
| 11-Jun-19 6:14 PM View: | Urovant Sciences Ltd. (UROV) | 11-Jun-19 | Market Purchase (Planned) Duplicate | 7,189 | $8.58 | $61,693.80 | < 1% 22.81M to 22.82M | 89% |
| 11-Jun-19 6:14 PM View: | Urovant Sciences Ltd. (UROV) | 10-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $8.35 | $62,594.20 | < 1% 22.81M to 22.81M | 94% |
| 11-Jun-19 6:14 PM View: | Urovant Sciences Ltd. (UROV) | 07-Jun-19 | Market Purchase (Planned) Duplicate | 6,649 | $7.97 | $52,959.30 | < 1% 22.8M to 22.81M | 104% |
| 06-Jun-19 6:16 PM View: | Urovant Sciences Ltd. (UROV) | 06-Jun-19 | Market Purchase (Planned) Duplicate | 7,082 | $8.00 | $56,621.30 | < 1% 22.79M to 22.8M | 103% |
| 06-Jun-19 6:16 PM View: | Urovant Sciences Ltd. (UROV) | 05-Jun-19 | Market Purchase (Planned) Duplicate | 6,540 | $8.02 | $52,418.10 | < 1% 22.78M to 22.79M | 102% |
| 13-Jun-19 3:45 PM View: | Myovant Sciences Ltd. (MYOV) | 04-Jun-19 | Private Purchase Duplicate | 2,424,240 | $8.25 | $20,000,000.00 | 6% 38.34M to 40.77M | |
| 06-Jun-19 6:16 PM View: | Urovant Sciences Ltd. (UROV) | 04-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $7.59 | $56,910.80 | < 1% 22.78M to 22.78M | 114% |
| 03-Jun-19 6:23 PM View: | Urovant Sciences Ltd. (UROV) | 03-Jun-19 | Market Purchase (Planned) Duplicate | 5,424 | $7.71 | $41,814.70 | < 1% 22.77M to 22.78M | 110% |
| 03-Jun-19 6:23 PM View: | Urovant Sciences Ltd. (UROV) | 31-May-19 | Market Purchase (Planned) Duplicate | 5,071 | $7.70 | $39,042.10 | < 1% 22.77M to 22.77M | 111% |
| 03-Jun-19 6:23 PM View: | Urovant Sciences Ltd. (UROV) | 30-May-19 | Market Purchase (Planned) Duplicate | 7,251 | $8.01 | $58,089.50 | < 1% 22.76M to 22.77M | 102% |
| 29-May-19 6:23 PM View: | Urovant Sciences Ltd. (UROV) | 29-May-19 | Market Purchase (Planned) Duplicate | 6,882 | $7.55 | $51,983.20 | < 1% 22.75M to 22.76M | 115% |
| 29-May-19 6:23 PM View: | Urovant Sciences Ltd. (UROV) | 28-May-19 | Market Purchase (Planned) Duplicate | 3,807 | $7.68 | $29,244.60 | < 1% 22.75M to 22.75M | 111% |
| 29-May-19 6:23 PM View: | Urovant Sciences Ltd. (UROV) | 24-May-19 | Market Purchase (Planned) Duplicate | 3,796 | $7.70 | $29,233.40 | < 1% 22.75M to 22.75M | 111% |
| 23-May-19 6:36 PM View: | Urovant Sciences Ltd. (UROV) | 23-May-19 | Market Purchase (Planned) Duplicate | 4,802 | $7.76 | $37,252.00 | < 1% 22.74M to 22.75M | 109% |
| 23-May-19 6:36 PM View: | Urovant Sciences Ltd. (UROV) | 22-May-19 | Market Purchase (Planned) Duplicate | 5,033 | $8.06 | $40,557.90 | < 1% 22.74M to 22.74M | 101% |
| 23-May-19 6:36 PM View: | Urovant Sciences Ltd. (UROV) | 21-May-19 | Market Purchase Duplicate | 9,995 | $8.52 | $85,108.40 | < 1% 22.73M to 22.74M | 90% |
| 20-May-19 9:23 PM View: | Urovant Sciences Ltd. (UROV) | 20-May-19 | Market Purchase Duplicate | 10,000 | $8.05 | $80,524.80 | (100%) (-10.0K) to 0 | 101% |
| 20-May-19 9:23 PM View: | Urovant Sciences Ltd. (UROV) | 17-May-19 | Market Purchase Duplicate | 6,200 | $7.36 | $45,641.30 | (100%) (-6.2K) to 0 | 120% |
| 20-May-19 9:23 PM View: | Urovant Sciences Ltd. (UROV) | 16-May-19 | Market Purchase Duplicate | 5,408 | $6.79 | $36,718.20 | < 1% 22.7M to 22.71M | 139% |
| 19-Mar-19 5:06 PM View: | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
| 20-Dec-18 9:38 AM View: | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
| 03-Oct-18 5:52 PM View: | Urovant Sciences Ltd. (UROV) | 01-Oct-18 | Purchase Duplicate | 2,678,570 | $14.00 | $37,500,000.00 | 13% 20.03M to 22.7M | |
| 07-Jun-18 8:21 AM View: | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
| 04-Apr-18 9:58 PM View: | Myovant Sciences Ltd. (MYOV) | 02-Apr-18 | Market Purchase Duplicate | 1,110,020 | $20.27 | $22,500,000.00 | 3% 37.23M to 38.34M | 5% |
| 08-Feb-16 9:43 PM View: | Editas Medicine, Inc. (EDIT) | 08-Feb-15 | Conversion Duplicate | 1,709,400 | -- | -- | 44% 3.93M to 5.64M | |
| 08-Feb-16 9:43 PM View: | Editas Medicine, Inc. (EDIT) | 08-Feb-15 | Conversion | 1,709,400 | -- | -- | 30% 5.64M to 7.35M | |
| 08-Feb-16 9:43 PM View: | Editas Medicine, Inc. (EDIT) | 08-Feb-15 | Purchase Duplicate | 1,020,410 | -- | -- | 14% 7.35M to 8.37M | |
| 08-Feb-16 9:43 PM View: | Editas Medicine, Inc. (EDIT) | 08-Feb-15 | Purchase | 1,020,410 | -- | -- | 12% 8.37M to 9.39M | |
| 08-Oct-14 6:32 PM View: | Wayfair Inc. (W) | 02-Oct-14 | Purchase Duplicate | 479,250 | -- | -- | 18% 2.69M to 3.17M | |
| 08-Oct-14 6:32 PM View: | Wayfair Inc. (W) | 02-Oct-14 | Purchase | 373,789 | -- | -- | 12% 3.17M to 3.55M |